Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. -- and one that’s already available in Europe and multiple other countries.
has bought 3.2 million Novavax doses so far, and Erck said vaccinations should begin later this month.
Her husband's positive experience with a more tried-and-true technology, "that convinced me," Bentley said, adding that she planned to tell some unvaccinated friends about the option, too. Like the other vaccines used in the U.S., the Novavax shots have proved highly effective at preventing COVID-19's most severe outcomes. Typical vaccine reactions were mild, including arm pain and fatigue. But FDA did warn about the possibility of a rare risk, heart inflammation, that also has been seen with the Pfizer and Moderna vaccines.struck.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
US regulators OK new COVID-19 shot option from NovavaxThe U.S. is getting another COVID-19 vaccine choice
続きを読む »
US regulators OK new COVID-19 shot option from NovavaxNovavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S.
続きを読む »
U.S. health officials approve new COVID-19 shot from NovavaxThe U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more...
続きを読む »
US regulators OK new COVID-19 shot option from NovavaxNovavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S.
続きを読む »
Masks urged in New York City as COVID-19 omicron subvariant BA.5 cases tick upAs COVID-19 cases tick up in New York City, the Department of Health is continuing to urge residents to wear masks in all public indoor settings and in crowded areas outdoors.
続きを読む »